Research Paper Volume 13, Issue 4 pp 5621—5637

Expression and prognostic values of ARID family members in breast cancer

Distinct expression of ARID members in breast cancer patients. (A) The mRNA expression of all the ARID members was assessed in cancer and normal tissues (p values were calculated grouping by Tumor(T)/Normal(N) and using t-test. (B–J) The mRNA expression of ARID1A, ARID1B, ARID2, ARID3A, ARID3C ARID4A, ARID4B, ARID5A, and JARID2 were assessed in different molecular subtypes(p values were calculated grouping by luminal A + luminal B VS. HER2-riched + basal-like and using t-test). (*p p p

Figure 1. Distinct expression of ARID members in breast cancer patients. (A) The mRNA expression of all the ARID members was assessed in cancer and normal tissues (p values were calculated grouping by Tumor(T)/Normal(N) and using t-test. (BJ) The mRNA expression of ARID1A, ARID1B, ARID2, ARID3A, ARID3C ARID4A, ARID4B, ARID5A, and JARID2 were assessed in different molecular subtypes(p values were calculated grouping by luminal A + luminal B VS. HER2-riched + basal-like and using t-test). (*p < 0.05, **p < 0.01,***p < 0.001).